Knowles Corp Stock Surpasses Analyst Target Price
- Stock Performance: Knowles Corp's shares have surpassed the average analyst 12-month target price of $26.50, currently trading at $26.98, indicating optimistic market expectations for the company's future performance.
- Analyst Reactions: When a stock reaches its target price, analysts may either downgrade their valuation or raise their target, reflecting varying perspectives on the company's fundamental improvements, which could influence investor decisions.
- Target Price Distribution: Among analysts covering Knowles Corp within Zacks, target prices vary significantly, with a low of $23.00 and a high of $30.00, and a standard deviation of $3.109, highlighting differing expectations for the company's future performance.
- Investor Signal: The stock's rise above the target price provides a signal for investors to reassess the company, prompting them to consider whether the current valuation is justified or if it is time to take profits to mitigate risk.
Trade with 70% Backtested Accuracy
Analyst Views on KN
About KN
About the author
Knowles Corp Stock Surpasses Analyst Target Price
- Stock Performance: Knowles Corp's shares have surpassed the average analyst 12-month target price of $26.50, currently trading at $26.98, indicating optimistic market expectations for the company's future performance.
- Analyst Reactions: When a stock reaches its target price, analysts may either downgrade their valuation or raise their target, reflecting varying perspectives on the company's fundamental improvements, which could influence investor decisions.
- Target Price Distribution: Among analysts covering Knowles Corp within Zacks, target prices vary significantly, with a low of $23.00 and a high of $30.00, and a standard deviation of $3.109, highlighting differing expectations for the company's future performance.
- Investor Signal: The stock's rise above the target price provides a signal for investors to reassess the company, prompting them to consider whether the current valuation is justified or if it is time to take profits to mitigate risk.
Knowles Corporation Reports Strong Q4 2025 Earnings Growth and Positive Outlook
- Significant Earnings Growth: Knowles Corporation reported Q4 2025 revenue of $162 million, a 14% year-over-year increase, with EPS at $0.36, up 33%, both exceeding expectations and demonstrating strong performance in high-growth markets.
- Robust Market Demand: The company highlighted strong demand across MedTech, Defense, Industrial, EV, and Energy sectors, particularly noting repeat orders and new design wins in high-performance ceramic capacitors and pulse power film capacitors, which further solidify its market position.
- Optimistic Future Outlook: Management guided Q1 2026 revenues between $143 million and $153 million, indicating a 12% year-over-year increase, with EPS projected between $0.22 and $0.26, showcasing ongoing growth potential.
- Capital Expenditure Plans: Knowles plans to keep full-year capital spending at approximately 4% to 5% of revenues, primarily driven by investments in expanding production capacity for energy orders, reflecting the company's confidence in future growth and strategic investment commitment.
Knowles (KN) to Announce Q4 Earnings on February 5th
- Earnings Announcement: Knowles is set to release its Q4 earnings on February 5th after market close, with market participants keenly observing the results for potential stock price impacts.
- Earnings Expectations: The consensus EPS estimate stands at $0.35, reflecting a 29.6% year-over-year increase, indicating significant improvement in profitability that could bolster investor confidence.
- Revenue Forecast: Revenue is projected at $156.22 million, representing a 9.6% year-over-year growth, showcasing the company's stable growth trajectory that may attract increased investor interest.
- Historical Performance: Over the past two years, Knowles has beaten EPS estimates 50% of the time and revenue estimates 75% of the time, demonstrating its financial reliability and adaptability in the market.
Knowles CEO Sells 5.62% of Shares Amid Positive Momentum
- Insider Sale: On January 15, 2026, Knowles CEO Jeffrey Niew executed a direct sale of 50,000 shares through multiple open-market transactions, totaling approximately $1.2375 million, indicating his ongoing confidence in the company's stock despite the sale.
- Change in Holdings: This sale represented 5.62% of Niew's direct holdings, marking the largest single open-market sale in recent history and more than double his recent median sell size of 2.73%, reflecting a trend of reduced holdings over the past year.
- Market Performance Analysis: The shares were sold at a weighted average price of $24.75, while the stock closed at $24.93 on the same day, suggesting that the sale occurred amid positive price momentum, with a total return of 24.5% over the past year.
- Investor Considerations: The transaction was executed as part of a Rule 10b5-1 trading plan, which allows insiders to trade shares on a predetermined basis, highlighting the need for investors to interpret insider activity cautiously without assuming strong conviction in the stock.
Knowles Stock is Currently Oversold (KN)
Current Trading Status: Knowles Corp (KN) shares have entered oversold territory with an RSI of 28.8, indicating potential exhaustion of recent selling pressure.
Price Performance: The stock's current price is $21.26, within a 52-week range of $12.19 (low) to $24.535 (high).
Investor Outlook: Bullish investors may view the low RSI as an opportunity to consider buying shares as selling may be slowing down.
Disclaimer: The opinions expressed in the article are those of the author and do not necessarily reflect the views of Nasdaq, Inc.
Knowles Anticipates 4%–6% Organic Growth in 2026 as Specialty Film Capacity Increases
Financial Performance: Knowles Corporation reported Q3 2025 revenue of $153 million, a 7% increase year-over-year, with EPS of $0.33, up 22%. The Precision Devices segment showed strong growth, contributing $88 million in revenue, while Medtech & Specialty Audio reached $65 million.
Growth Outlook: Management anticipates continued growth, projecting organic growth rates at the high end of 4% to 6% for 2026, with Q4 2025 revenue guidance between $151 million and $161 million. The Precision Devices segment is expected to grow at 6% to 8% in 2025.
Operational Highlights: Gross margins improved, with Medtech & Specialty Audio at 53% and Precision Devices at 41.5%. The company is focused on expanding specialty film capacity and has a strong balance sheet to support growth investments and share buybacks.
Analyst Sentiment: Analysts expressed optimism regarding specialty film growth, backlog strength, and margin improvements, with management maintaining a confident tone about operational execution and strategic acquisitions, positioning the company well for future growth.
Knowles Corp Stock Surpasses Analyst Target Price
- Stock Performance: Knowles Corp's shares have surpassed the average analyst 12-month target price of $26.50, currently trading at $26.98, indicating optimistic market expectations for the company's future performance.
- Analyst Reactions: When a stock reaches its target price, analysts may either downgrade their valuation or raise their target, reflecting varying perspectives on the company's fundamental improvements, which could influence investor decisions.
- Target Price Distribution: Among analysts covering Knowles Corp within Zacks, target prices vary significantly, with a low of $23.00 and a high of $30.00, and a standard deviation of $3.109, highlighting differing expectations for the company's future performance.
- Investor Signal: The stock's rise above the target price provides a signal for investors to reassess the company, prompting them to consider whether the current valuation is justified or if it is time to take profits to mitigate risk.
Knowles Corporation Reports Strong Q4 2025 Earnings Growth and Positive Outlook
- Significant Earnings Growth: Knowles Corporation reported Q4 2025 revenue of $162 million, a 14% year-over-year increase, with EPS at $0.36, up 33%, both exceeding expectations and demonstrating strong performance in high-growth markets.
- Robust Market Demand: The company highlighted strong demand across MedTech, Defense, Industrial, EV, and Energy sectors, particularly noting repeat orders and new design wins in high-performance ceramic capacitors and pulse power film capacitors, which further solidify its market position.
- Optimistic Future Outlook: Management guided Q1 2026 revenues between $143 million and $153 million, indicating a 12% year-over-year increase, with EPS projected between $0.22 and $0.26, showcasing ongoing growth potential.
- Capital Expenditure Plans: Knowles plans to keep full-year capital spending at approximately 4% to 5% of revenues, primarily driven by investments in expanding production capacity for energy orders, reflecting the company's confidence in future growth and strategic investment commitment.
Knowles (KN) to Announce Q4 Earnings on February 5th
- Earnings Announcement: Knowles is set to release its Q4 earnings on February 5th after market close, with market participants keenly observing the results for potential stock price impacts.
- Earnings Expectations: The consensus EPS estimate stands at $0.35, reflecting a 29.6% year-over-year increase, indicating significant improvement in profitability that could bolster investor confidence.
- Revenue Forecast: Revenue is projected at $156.22 million, representing a 9.6% year-over-year growth, showcasing the company's stable growth trajectory that may attract increased investor interest.
- Historical Performance: Over the past two years, Knowles has beaten EPS estimates 50% of the time and revenue estimates 75% of the time, demonstrating its financial reliability and adaptability in the market.
Knowles CEO Sells 5.62% of Shares Amid Positive Momentum
- Insider Sale: On January 15, 2026, Knowles CEO Jeffrey Niew executed a direct sale of 50,000 shares through multiple open-market transactions, totaling approximately $1.2375 million, indicating his ongoing confidence in the company's stock despite the sale.
- Change in Holdings: This sale represented 5.62% of Niew's direct holdings, marking the largest single open-market sale in recent history and more than double his recent median sell size of 2.73%, reflecting a trend of reduced holdings over the past year.
- Market Performance Analysis: The shares were sold at a weighted average price of $24.75, while the stock closed at $24.93 on the same day, suggesting that the sale occurred amid positive price momentum, with a total return of 24.5% over the past year.
- Investor Considerations: The transaction was executed as part of a Rule 10b5-1 trading plan, which allows insiders to trade shares on a predetermined basis, highlighting the need for investors to interpret insider activity cautiously without assuming strong conviction in the stock.
Knowles Stock is Currently Oversold (KN)
Current Trading Status: Knowles Corp (KN) shares have entered oversold territory with an RSI of 28.8, indicating potential exhaustion of recent selling pressure.
Price Performance: The stock's current price is $21.26, within a 52-week range of $12.19 (low) to $24.535 (high).
Investor Outlook: Bullish investors may view the low RSI as an opportunity to consider buying shares as selling may be slowing down.
Disclaimer: The opinions expressed in the article are those of the author and do not necessarily reflect the views of Nasdaq, Inc.
Knowles Anticipates 4%–6% Organic Growth in 2026 as Specialty Film Capacity Increases
Financial Performance: Knowles Corporation reported Q3 2025 revenue of $153 million, a 7% increase year-over-year, with EPS of $0.33, up 22%. The Precision Devices segment showed strong growth, contributing $88 million in revenue, while Medtech & Specialty Audio reached $65 million.
Growth Outlook: Management anticipates continued growth, projecting organic growth rates at the high end of 4% to 6% for 2026, with Q4 2025 revenue guidance between $151 million and $161 million. The Precision Devices segment is expected to grow at 6% to 8% in 2025.
Operational Highlights: Gross margins improved, with Medtech & Specialty Audio at 53% and Precision Devices at 41.5%. The company is focused on expanding specialty film capacity and has a strong balance sheet to support growth investments and share buybacks.
Analyst Sentiment: Analysts expressed optimism regarding specialty film growth, backlog strength, and margin improvements, with management maintaining a confident tone about operational execution and strategic acquisitions, positioning the company well for future growth.
